{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:45:34Z","timestamp":1790477134799,"version":"4.1.0"},"reference-count":62,"publisher":"American Society of Hematology","issue":"22","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be caused by maternal immunoglobulin G alloantibodies against the human platelet antigen 1a (HPA-1a), a Leu33Pro polymorphism at the plexin-semaphorin-integrin (PSI) domain of the \u03b23 subunit shared by integrins \u03b1IIb\u03b23 and \u03b1V\u03b23. Although serologic detection of anti\u2013HPA-1a alloantibodies has long aided FNAIT diagnosis, the disease remains a major clinical challenge due to unpredictable severe outcomes, particularly intracranial hemorrhage and fetal loss. To define the molecular basis of HPA-1a immunogenicity and antibody pathogenicity, we determined crystal structures of the HPA-1a antigen bound to Fabs from 4 anti\u2013HPA-1a monoclonal antibodies, including 3 clinically relevant maternal alloantibodies (26.4, D-204, and M-204) and 1 murine antibody (SZ21). The structures reveal that all antibodies recognize an HPA-1a epitope centered on Leu33, spanning both PSI and integrin-epidermal growth factor (I-EGF) 1 domains of \u03b23 integrin. Variations in antibody-binding interfaces account for differential affinities to both \u03b1IIb\u03b23 and \u03b1V\u03b23, whereas distinct binding orientations determine whether antibody engagement stabilizes the bent inactive \u03b23 conformation. Functional assays demonstrated antibody-dependent inhibition of \u03b1IIb\u03b23-mediated platelet aggregation, thrombus formation, and clot retraction, as well as \u03b1V\u03b23-mediated endothelial adhesion and spreading. These results establish the structural framework of HPA-1a alloantigenicity, explain the conformational selectivity of anti\u2013HPA-1a antibodies, and elucidate how they block integrin activation. The findings provide mechanistic insight into FNAIT pathogenesis and suggest that antibody heterogeneity in affinity and function may contribute to clinical variability. Furthermore, these findings demonstrate antibody-mediated stabilization of the PSI\/I-EGF1 domain as a potential strategy for allosteric modulation of integrin structure and function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032546","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:13:01Z","timestamp":1770840781000},"page":"2569-2581","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Structural basis of HPA-1a alloimmunization in FNAIT and allosteric regulation of integrin conformation"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-2464","authenticated-orcid":false,"given":"Heng","family":"Zhang","sequence":"first","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Paddock","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-2594","authenticated-orcid":false,"given":"Janita J.","family":"Oosterhoff","sequence":"additional","affiliation":[{"name":"2Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands"},{"name":"3Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong T. T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-3740","authenticated-orcid":false,"given":"Huiying","family":"Zhi","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Wang","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-1668","authenticated-orcid":false,"given":"Douglas","family":"Sheridan","sequence":"additional","affiliation":[{"name":"4Rallybio LLC, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-8419","authenticated-orcid":false,"given":"Tor B.","family":"Stuge","sequence":"additional","affiliation":[{"name":"5Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Troms\u00f8, Norway"},{"name":"6Department of Laboratory Medicine, University Hospital of North Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Ghevaert","sequence":"additional","affiliation":[{"name":"7Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-0801","authenticated-orcid":false,"given":"Debra K.","family":"Newman","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"},{"name":"8Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[{"name":"2Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands"},{"name":"3Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8853-7707","authenticated-orcid":false,"given":"Peter J.","family":"Newman","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"},{"name":"8Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI"},{"name":"9Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-4263","authenticated-orcid":false,"given":"Jieqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI"},{"name":"10Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2026052811220095700_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000547985","article-title":"Diagnosis and management of fetal and neonatal alloimmune thrombocytopenia: an update 2025","volume":"52","author":"Sachs","year":"2025","journal-title":"Transfus Med Hemother"},{"key":"2026052811220095700_bib2","doi-asserted-by":"crossref","first-page":"101038","DOI":"10.1016\/j.blre.2022.101038","article-title":"Fetal and neonatal alloimmune thrombocytopenia: current pathophysiological insights and perspectives for future diagnostics and treatment","volume":"59","author":"Stam","year":"2023","journal-title":"Blood Rev"},{"issue":"1","key":"2026052811220095700_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.siny.2015.12.004","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"21","author":"Zdravic","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"2026052811220095700_bib4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"issue":"8","key":"2026052811220095700_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"issue":"2","key":"2026052811220095700_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0198-8859(90)90104-W","article-title":"HLA-DRw52a is involved in alloimmunization against PL-A1 antigen","volume":"27","author":"Valentin","year":"1990","journal-title":"Hum Immunol"},{"issue":"8","key":"2026052811220095700_bib7","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI118980","article-title":"Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia","volume":"98","author":"Maslanka","year":"1996","journal-title":"J Clin Invest"},{"issue":"16","key":"2026052811220095700_bib8","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2008-09-178475","article-title":"T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3\u22170101-restricted CD4+ T cells","volume":"113","author":"Ahlen","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2026052811220095700_bib9","doi-asserted-by":"crossref","first-page":"102707","DOI":"10.1016\/j.transci.2019.102707","article-title":"Foetal and neonatal alloimmune thrombocytopenia - the role of the HLA-DRB3\u221701:01 allele for HPA-1a-immunisation and foetal\/neonatal outcome","volume":"59","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"2026052811220095700_bib10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"11","key":"2026052811220095700_bib11","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V85.11.3028.bloodjournal85113028","article-title":"Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response","volume":"85","author":"Valentin","year":"1995","journal-title":"Blood"},{"issue":"21","key":"2026052811220095700_bib12","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/bloodadvances.2018023341","article-title":"High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1)","volume":"2","author":"Zhi","year":"2018","journal-title":"Blood Adv"},{"issue":"9","key":"2026052811220095700_bib13","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/trf.15960","article-title":"Naturally occurring point mutation Cys460Trp located in the I-EGF1 domain of integrin \u03b23 alters the binding of some anti-HPA-1a antibodies","volume":"60","author":"Holzwarth","year":"2020","journal-title":"Transfusion"},{"issue":"1-2","key":"2026052811220095700_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jim.2011.10.008","article-title":"Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin \u03b1IIb\u03b23 (GPIIb\/IIIa)","volume":"375","author":"Allen","year":"2012","journal-title":"J Immunol Methods"},{"issue":"1","key":"2026052811220095700_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.V86.1.234.bloodjournal861234","article-title":"The impact of three-dimensional structure on the expression of PIA alloantigens on human integrin \u03b23","volume":"86","author":"Honda","year":"1995","journal-title":"Blood"},{"issue":"39","key":"2026052811220095700_bib16","doi-asserted-by":"crossref","first-page":"E9105","DOI":"10.1073\/pnas.1806205115","article-title":"Autonomous conformational regulation of \u03b23 integrin and the conformation-dependent property of HPA-1a alloantibodies","volume":"115","author":"Thinn","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2026052811220095700_bib17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.2025029618","article-title":"HPA-1a antibodies in FNAIT do not distinguish \u03b1V\u03b23 from \u03b1IIb\u03b23, and bind inactive integrins more strongly than active integrins","volume":"146","author":"Oosterhoff","year":"2025","journal-title":"Blood"},{"issue":"3","key":"2026052811220095700_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molimm.2008.10.015","article-title":"HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity","volume":"46","author":"van Gils","year":"2009","journal-title":"Mol Immunol"},{"issue":"4","key":"2026052811220095700_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH03-07-0484","article-title":"The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function","volume":"91","author":"Joutsi-Korhonen","year":"2004","journal-title":"Thromb Haemost"},{"issue":"4","key":"2026052811220095700_bib20","first-page":"280","article-title":"Effect of the binding of anti-Zwa antibodies on platelet function","volume":"47","author":"van Leeuwen","year":"1984","journal-title":"Vox Sang"},{"key":"2026052811220095700_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2017.12.017","article-title":"Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets","volume":"162","author":"Refsum","year":"2018","journal-title":"Thromb Res"},{"issue":"12","key":"2026052811220095700_bib22","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.4049\/jimmunol.1401599","article-title":"Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy","volume":"194","author":"Eksteen","year":"2015","journal-title":"J Immunol"},{"issue":"6","key":"2026052811220095700_bib23","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1160\/TH05-03-0159","article-title":"Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a","volume":"94","author":"Kroll","year":"2005","journal-title":"Thromb Haemost"},{"issue":"8","key":"2026052811220095700_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1V\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2026052811220095700_bib25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet \u03b23 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbare","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"2026052811220095700_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00005-015-0371-9","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: pathogenesis, diagnostics and prevention","volume":"64","author":"Brojer","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"4","key":"2026052811220095700_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tmrv.2020.09.004","article-title":"Fetal and neonatal alloimmune thrombocytopenia-new prospects for fetal risk assessment of HPA-1a-negative pregnant women","volume":"34","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"2","key":"2026052811220095700_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000487303","article-title":"Management and neonatal outcomes of pregnancies with fetal\/neonatal alloimmune thrombocytopenia: a single-center retrospective cohort study","volume":"45","author":"Ronzoni","year":"2019","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"2026052811220095700_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tracli.2017.05.010","article-title":"Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation","volume":"24","author":"Petermann","year":"2017","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"2026052811220095700_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.13274","article-title":"Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage","volume":"56","author":"Delbos","year":"2016","journal-title":"Transfusion"},{"issue":"7","key":"2026052811220095700_bib31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2007.01273.x","article-title":"HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"issue":"4","key":"2026052811220095700_bib32","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S2352-3026(25)00029-8","article-title":"Rising to the challenge: an international Delphi consensus study on fetal and neonatal alloimmune thrombocytopenia","volume":"12","author":"Pothof","year":"2025","journal-title":"Lancet Haematol"},{"key":"2026052811220095700_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/aob.2019.12.04","article-title":"Platelet physiology and immunology: pathogenesis and treatment of classical and non-classical fetal and neonatal alloimmune thrombocytopenia","volume":"4","author":"Chen","year":"2019","journal-title":"Ann Blood"},{"issue":"6","key":"2026052811220095700_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric, signalling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"issue":"1","key":"2026052811220095700_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceb.2011.10.004","article-title":"Integrin inside-out signaling and the immunological synapse","volume":"24","author":"Springer","year":"2012","journal-title":"Curr Opin Cell Biol"},{"issue":"13","key":"2026052811220095700_bib36","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2016-07-729400","article-title":"The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy","volume":"129","author":"Zhu","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2026052811220095700_bib37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-01-829572","article-title":"Structure of an extended \u03b23 integrin","volume":"132","author":"Zhou","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2026052811220095700_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/trf.17758","article-title":"Generation of human antibodies targeting human platelet antigen (HPA)-1a","volume":"64","author":"Oosterhoff","year":"2024","journal-title":"Transfusion"},{"issue":"8","key":"2026052811220095700_bib39","first-page":"2929","article-title":"Developing recombinant HPA-1a-specific antibodies with abrogated Fc\u03b3 receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia","volume":"118","author":"Ghevaert","year":"2008","journal-title":"J Clin Invest"},{"issue":"12","key":"2026052811220095700_bib40","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood.V86.12.4430.bloodjournal86124430","article-title":"A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library","volume":"86","author":"Griffin","year":"1995","journal-title":"Blood"},{"issue":"3","key":"2026052811220095700_bib41","first-page":"239","article-title":"Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application","volume":"34","author":"Xi","year":"1992","journal-title":"Nouv Rev Fr Hematol (1978)"},{"issue":"5","key":"2026052811220095700_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0039.1995.tb03129.x","article-title":"A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2","volume":"46","author":"Weiss","year":"1995","journal-title":"Tissue Antigens"},{"issue":"W1","key":"2026052811220095700_bib43","doi-asserted-by":"crossref","first-page":"W482","DOI":"10.1093\/nar\/gkz358","article-title":"AppA: a web server for analysis, comparison, and visualization of contact residues and interfacial waters of antibody-antigen structures and models","volume":"47","author":"Nguyen","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2026052811220095700_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.transci.2003.10.004","article-title":"Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA-1a screening of blood donors and pregnant women","volume":"30","author":"Killie","year":"2004","journal-title":"Transfus Apher Sci"},{"issue":"9","key":"2026052811220095700_bib45","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1182\/blood.V93.9.2959.409k20_2959_2967","article-title":"Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s)","volume":"93","author":"Barron-Casella","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2026052811220095700_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.molcel.2008.11.018","article-title":"Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces","volume":"32","author":"Zhu","year":"2008","journal-title":"Mol Cell"},{"issue":"44","key":"2026052811220095700_bib47","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1021\/bi300734n","article-title":"\u03b1V\u03b23 integrin crystal structures and their functional implications","volume":"51","author":"Dong","year":"2012","journal-title":"Biochemistry"},{"issue":"4","key":"2026052811220095700_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1083\/jcb.200905085","article-title":"Crystal structure of the complete integrin \u03b1V\u03b23 ectodomain plus an \u03b1\/\u03b2 transmembrane fragment","volume":"186","author":"Xiong","year":"2009","journal-title":"J Cell Biol"},{"issue":"7013","key":"2026052811220095700_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature02976","article-title":"Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics","volume":"432","author":"Xiao","year":"2004","journal-title":"Nature"},{"issue":"6","key":"2026052811220095700_bib50","first-page":"1095","article-title":"Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists","volume":"84","author":"Jennings","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5 pt 2 Su","key":"2026052811220095700_bib51","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S0002-8703(98)70246-7","article-title":"Expression of ligand-induced binding sites on glycoprotein IIb\/IIIa complexes and the effect of various inhibitors","volume":"135","author":"Jennings","year":"1998","journal-title":"Am Heart J"},{"issue":"2","key":"2026052811220095700_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1538-7836.2008.02858.x","article-title":"Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies","volume":"6","author":"Stafford","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"18","key":"2026052811220095700_bib53","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood.2025030524","article-title":"In pursuit of FNAIT biomarkers: \u03b1V\u03b23 specificity falls short","volume":"146","author":"Newman","year":"2025","journal-title":"Blood"},{"issue":"1","key":"2026052811220095700_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"2026052811220095700_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood-2012-11-468561","article-title":"Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia","volume":"122","author":"Bakchoul","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2026052811220095700_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MOH.0b013e328358f86c","article-title":"Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia","volume":"19","author":"Kjeldsen-Kragh","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2026052811220095700_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1537-2995.2008.01972.x","article-title":"Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia","volume":"49","author":"Bakchoul","year":"2009","journal-title":"Transfusion"},{"issue":"20","key":"2026052811220095700_bib58","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026052811220095700_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/immunohorizons.2100097","article-title":"Prevention of fetal\/neonatal alloimmune thrombocytopenia in mice: biochemical and cell biological characterization of Isoforms of a human monoclonal antibody","volume":"6","author":"Mortberg","year":"2022","journal-title":"Immunohorizons"},{"issue":"3","key":"2026052811220095700_bib60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2013-02-481887","article-title":"Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers","volume":"122","author":"Ghevaert","year":"2013","journal-title":"Blood"},{"issue":"suppl 1","key":"2026052811220095700_bib61","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/jth.12915","article-title":"\u03b1IIb\u03b23: structure and function","volume":"13","author":"Coller","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"16","key":"2026052811220095700_bib62","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1182\/bloodadvances.2024013177","article-title":"An \u03b1IIb\u03b23 monoclonal antibody traps a semiextended conformation and allosterically inhibits large ligand binding","volume":"8","author":"Wang","year":"2024","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/22\/2569\/2522837\/blood_bld-2025-032546-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/22\/2569\/2522837\/blood_bld-2025-032546-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:22:15Z","timestamp":1779981735000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/22\/2569\/566571\/Structural-basis-of-HPA-1a-alloimmunization-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":62,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032546","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,28]]},"published":{"date-parts":[[2026,5,28]]}}}